Adenoma-like and non-adenoma-like dysplasia-associated lesion or mass in ulcerative colitis

Journal of Digestive Diseases

Volumn 14, Issue 4, 2013, Pages 157-159

  Chen, Ying Xuan ^a   Qiao, Liang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colonoscopy; Colorectal neoplasm; Dysplasia associated lesion or mass; Endoscopy; Ulcerative colitis

Indexed keywords

ARTICLE; CANCER RISK; CHROMOENDOSCOPY; COLON ADENOMA; COLON INJURY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DYSPLASIA; DYSPLASIA ASSOCIATED LESION OR MASS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADENOMA; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRECANCEROUS CONDITIONS; RISK ASSESSMENT;

EID: 84875607913     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12043     Document Type: Article

References (15)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535.
2. Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res 2011; 4: 53-61.
3. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 746-774, 774.e1-4; quiz e12-3.
4. Rutter MD, Saunders BP, Wilkinson KH etal. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130: 1030-1038.
5. Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroenterol Clin Biol 2009; 33 (Suppl 3): S190-201.
6. Neumann H, Vieth M, Langner C, Neurath MF, Mudter J. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011; 17: 3184-3191.
7. Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385.
8. Buda A, Lamboglia F, Hatem G, D'Incà R, Sturniolo GC. Evolving endoscopic technologies for the detection of dysplasia in inflammatory bowel diseases. Ann Ital Chir 2011; 82: 29-35.
9. Farraye FA, Odze RD, Eaden J etal. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 738-745.
10. Elsadani NN, East JE, Walters JR. New 2010 British Society of Gastroenterology colitis surveillance guidelines: costs and surveillance intervals. Gut 2011; 60: 282-283.
11. Shukla R, Abidi WM, Richards-Kortum R, Anandasabapathy S. Endoscopic imaging: how far are we from real-time histology? World J Gastrointest Endosc 2011; 3: 183-194.
12. Ortner MA, Fusco V, Ebert B etal. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 2010; 71: 312-318.
13. Fusco V, Ebert B, Weber-Eibel J etal. Cancer prevention in ulcerative colitis: long-term outcome following fluorescence-guided colonoscopy. Inflamm Bowel Dis 2012; 18: 489-495.
14. Salvatori F, Siciliano S, Maione F etal. Confocal laser endomicroscopy in the study of colonic mucosa in IBD patients: a review. Gastroenterol Res Pract 2012; [epub ahead of print]. doi: 10.1155/2012/525098.
15. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004; 2: 534-541.